Otsuka Holdings Co., Ltd.
http://www.otsuka.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Otsuka Holdings Co., Ltd.
Finance Watch: Venture Rounds Trend Toward The High End
Private Company Edition: First quarter data again confirm fewer but larger VC rounds in Q1. Big Q2 rounds include a $132.5m series C round for Endeavor Biomedicines, a $103m series A round for Reunion Neuroscience and Enlaza’s $100m series A.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Strong Sales, Deals Propel China Biotechs To 2023 Profitability
Strong sales growth and licensing activity in 2023 helped multiple Chinese biotechs to a solid profit performance, some moving into the black for the first time.
First Digital Therapeutic App Filed For Approval In Expanding Japan ADHD Market
A pioneering approval filing for a therapeutic app by Shionogi is set to herald expansion of ADHD therapies beyond the pill in Japan, along with growth in the pediatric segment for the disorder.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Alamo Pharmaceuticals, LLC
- Astex Pharmaceuticals, Inc.
- Avanir Pharmaceuticals, Inc.
- Daiya Foods Inc.
- Diatranz Otsuka Limited
- JIMRO Co., Ltd.
- Korea Otsuka Pharmaceutical Co., Ltd.
- Mitsui & Co., Ltd
- Montigen Pharmaceuticals
- Neurovance, Inc.
- Otsuka Australia Pharmaceutical Pty Ltd
- Otsuka Pharmaceutical Factory, Inc.
- Otsuka Medical Devices Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd
- Otsuka Pharmaceutical India Private Limited
- ReCor Medical, Inc.
- Singapore Otsuka Pharmaceutical Co., Ltd.
- SuperGen, Inc.
- Taiwan Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Taiho Pharma Canada, Inc.
- Visterra Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice